Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis

Multiple comparisons among means

Dunn, O. J. (1961) · Journal of the American Statistical Association · doi:10.1080/01621459.1961.10482090 · Cited by 5,006 · see citing works

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

Selmaj, K. W., & Raine, C. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230405 · Cited by 1,357 · see citing works

Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin Resistance

Beutler, B., Krochin, N., Milsark, I. W., Luedke, C. E., & Cerami, A. (1986) · Science · doi:10.1126/science.3754653 · Cited by 1,268 · see citing works

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202 · see citing works

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.

Moreira, A. L., Sampaio, E. P., Zmuidzinas, A., Frindt, P., Smith, K. A., & Kaplan, G. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.6.1675 · Cited by 1,041 · see citing works

Tumor necrosis factor identified in multiple sclerosis brain.

Hofman, F. M., Hinton, D. R., Johnson, K. P., & Merrill, J. E. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.2.607 · Cited by 801 · see citing works

The adhesion molecule and cytokine profile of multiple sclerosis lesions

Cannella, B., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370404 · Cited by 759 · see citing works

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

Selmaj, K. W., Raine, C. S., Cannella, B., & Brosnan, C. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115102 · Cited by 726 · see citing works

X-linked adrenoleukodystrophy

Moser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663 · see citing works

Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants

van Rood, J. J., LEEUWEN, A. V., & Ploem, J. S. (1976) · Nature · doi:10.1038/262795a0 · Cited by 489 · see citing works

Adrenoleukodystrophy: A Clinical and Pathological Study of 17 Cases

Schaumburg, H. H. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510033001 · Cited by 475 · see citing works

A SIMPLE MICRO CYTOTOXICITY TEST

Amos, D. B., Bashir, H., Boyle, W., MacQueen, M., & Tiilikainen, A. S. (1969) · Transplantation · doi:10.1097/00007890-196903000-00023 · Cited by 441 · see citing works

Qualitative alteration in substrate specificity of mitochondrial monoamine oxidase in brain

Moskvitina, T. A., Kamyshanskaya, N. S., Kaverina, L. P., & Gorkin, V. Z. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb04462.x · Cited by 440 · see citing works

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dememtia

Wesselingh, S. L., Power, C., Glass, J. D., Tyor, W. R., McArthur, J. C., Farber, J. M., Griffin, J. W., & Griffin, D. E. (1993) · Annals of Neurology · doi:10.1002/ana.410330604 · Cited by 414 · see citing works

Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.

Hofman, F. M., von Hanwehr, R., Dinarello, C. A., Mizel, S. B., Hinton, D. R., & Merrill, J. E. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.9.3239 · Cited by 317 · see citing works

The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein

Mosser, J., Lutz, Y., Stoeckel, M. E., Sarde, C. O., Kretz, C., Douar, A. M., Lopez, J., Aubourg, P., & Mandel, J. L. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.2.265 · Cited by 281 · see citing works

The Inflammatory Myelinopathy of Adreno-Leukodystrophy: Cells, Effector Molecules, and Pathogenetic Implications

POWERS, J. M., LIU, Y., MOSER, A. B., & MOSER, H. W. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199211000-00007 · Cited by 265 · see citing works

Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridization

Woodroofe, M. N., & Cuzner, M. L. (1993) · Cytokine · doi:10.1016/s1043-4666(05)80008-0 · Cited by 243 · see citing works

Adrenoleukodystrophy: Phenotypic variability and implications for therapy

Moser, H. W., Moser, A. B., Smith, K. D., Bergin, A., Borel, J., Shankroff, J., Stine, O. C., Merette, C., Ott, J., Krivit, W., et al. (1992) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799621 · Cited by 239 · see citing works

Estimation of the Means of Dependent Variables

Dunn, O. J. (1958) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177706443 · Cited by 209 · see citing works

Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis

Woodroofe, M. N., Bellamy, A. S., Feldmann, M., DAVISON, A. N., & Cuzner, M. L. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90100-0 · Cited by 186 · see citing works

MR findings in adult-onset adrenoleukodystrophy.

Kumar, A. J., Köhler, W., Kruse, B., Naidu, S., Bergin, A. M. R., Edwin, D. H., & Moser, H. W. (1995) · PubMed Central · Cited by 132 · see citing works

Altered expression of ALDP in X-linked adrenoleukodystrophy.

(1995) · PubMed Central · Cited by 127 · see citing works

X-linked adrenoleukodystrophy (ALD): A novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes

Berger, J., Molzer, B., Fae, I., & Bernheimer, H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2855 · Cited by 126 · see citing works

Human leukocyte antigen studies in multiple sclerosis

Hillert, J. A. (1994) · Annals of Neurology · doi:10.1002/ana.410360706 · Cited by 122 · see citing works

Molecular genetics of metachromatic leukodystrophy

Gieselmann, V., Zlotogora, J., Harris, A., Wenger, D. A., & Morris, C. P. (1994) · Human Mutation · doi:10.1002/humu.1380040402 · Cited by 116 · see citing works

Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy

Griffin, D. E., Moser, H. W., Mendoza, Q. P., Moench, T. R., O'Toole, S., & Moser, A. B. (1985) · Annals of Neurology · doi:10.1002/ana.410180606 · Cited by 107 · see citing works

Mutational analysis of patients with X-linked adrenoleukodystrophy

Kok, F., Neumann, S., Sarde, C.-O., Zheng, S., Wu, K.-H., Wei, H.-M., Bergin, J., Watkins, P. A., Gould, S., Sack, G., et al. (1995) · Human Mutation · doi:10.1002/humu.1380060203 · Cited by 103 · see citing works

Phospholipids in X-linked adrenoleukodystrophy white matter: Fatty acid abnormalities before the onset of demyelination

Theda, C., Moser, A. B., Powers, J. M., & Moser, H. W. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90028-j · Cited by 99 · see citing works

Human disease: Mechanisms in multiple sclerosis

Waksman, B. H. (1985) · Nature · doi:10.1038/318104a0 · Cited by 99 · see citing works

X-linked adrenoleukodystrophy

Moser, H. W. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815041 · Cited by 96 · see citing works

PREDICTION OF SUSCEPTIBILITY TO RHEUMATOID ARTHRITIS BY HUMAN LEUKOCYTE ANTIGEN GENOTYPING

Nepom, G. T., & Nepom, B. S. (1992) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00151-4 · Cited by 92 · see citing works

Cytokine expression of macrophages in HIV‐1‐associated vacuolar myelopathy

Tyor, W. R., Glass, J. D., Baumrind, N. L., McArthur, J. C., Griffin, J. W., Becker, P. S., & Griffin, D. E. (1993) · Neurology · doi:10.1212/wnl.43.5.1002 · Cited by 87 · see citing works

Brain gangliosides in adrenoleukodystrophy1

Igarashi, M., Belchjs, D., & Suzuki, K. (1976) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1976.tb01593.x · Cited by 81 · see citing works

Identification of a two base pair deletion in five unrelated families with adrenoleukodystrophy: A possible hot spot for mutations

Kemp, S., Ligtenberg, M. J. L., Vangeel, B. M., Barth, P. G., Wolterman, R. A., Schoute, F., Sarde, C. O., Mandel, J. L., Vanoost, B. A., & Bolhuis, P. A. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1979 · Cited by 75 · see citing works

HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis

Bias, W. Β., Hsu, S. H., Pollard, M., Harvey, J., Lotze, M. T., Arnett, F. C., & Stevens, M. B. (1981) · Human Immunology · doi:10.1016/0198-8859(81)90062-8 · Cited by 72 · see citing works

Fatty Acid Composition of Human Myelin Proteolipid Protein in Peroxisomal Disorders

Bizzozero, O. A., Zuñiga, G., & Lees, M. B. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02003.x · Cited by 61 · see citing works

Tumor necrosis factor-α and X-linked adrenoleukodystrophy

McGuinness, M. C., Griffin, D. E., Raymond, G. V., Washington, C., Moser, H. W., & Smith, K. D. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00084-f · Cited by 54 · see citing works

Clinical variation in X-linked adrenoleukodystrophy: Fatty acid and lipid metabolism in cultured fibroblasts

Boles, D. J., Craft, D. A., Padgett, D. A., Loria, R. M., & Rizzo, W. B. (1991) · Biochemical Medicine and Metabolic Biology · doi:10.1016/0885-4505(91)90010-i · Cited by 32 · see citing works

Histocompatibility Workshop and Conference

Terasaki, P. I. (1979) · Tissue Antigens · doi:10.1111/j.1399-0039.1979.tb00825.x · Cited by 28 · see citing works

A Race-Controlled Human Leukocyte Antigen Frequency Analysis in Lupus Nephritis

Freedman, B. I., Spray, B. J., Heise, E. R., Espeland, M. A., & Canzanello, V. J. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80264-2 · Cited by 23 · see citing works

Regulation of interferon‐γ mRNA in a cytolytic T cell clone: Ca2+‐induced transcription followed by mRNA stabilization through activation of protein kinase C or increase in cAMP

Kaldy, P., & Schmitt‐Verhulst, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250405 · Cited by 21 · see citing works

Association of X-Linked Adrenoleukodystrophy with HLA DRB1 Alleles

Berger, J., Bernheimer, H., Fae, I., Braun, A., Roscher, A., Molzer, B., & Fischer, G. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2643 · Cited by 16 · see citing works

Adrenoleukodystrophy

Kishimoto, Y., Moser, H. W., & Suzuki, K. (1999) · Springer eBooks · doi:10.1007/978-1-4757-0797-7_8 · Cited by 4 · see citing works

Inflammasomes in the CNS

Walsh, J. G., Muruve, D. A., & Power, C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3638 · Cited by 637 · see citing works

The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective

Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-7 · Cited by 565 · see citing works

Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases

Neumann, H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02154-9 · Cited by 480 · see citing works

Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology

Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31450 · Cited by 433 · see citing works

Interleukin‐1: A master regulator of neuroinflammation

Basu, A., Krady, J. K., & Levison, S. W. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20266 · Cited by 367 · see citing works

ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations

Kemp, S., Pujol, A., Waterham, H. R., van Geel, B. M., Boehm, C. D., Raymond, G. V., Cutting, G. R., Wanders, R. J. A., & Moser, H. W. (2001) · Human Mutation · doi:10.1002/humu.1227 · Cited by 332 · see citing works

A mouse model for X-linked adrenoleukodystrophy

Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293 · see citing works

X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects

Kemp, S., Berger, J., & Aubourg, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.012 · Cited by 283 · see citing works

IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases

Wooff, Y., Man, S. M., Aggio‐Bruce, R., Natoli, R., & Fernando, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01618 · Cited by 244 · see citing works

Chronic Interleukin-1β Expression in Mouse Brain Leads to Leukocyte Infiltration and Neutrophil-Independent Blood–Brain Barrier Permeability without Overt Neurodegeneration

Shaftel, S. S., Carlson, T. J., Olschowka, J. A., Kyrkanides, S., Matousek, S. B., & O'Banion, M. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1418-07.2007 · Cited by 243 · see citing works

Cytokine-mediated Induction of Ceramide Production Is Redox-sensitive

Singh, I., Pahan, K., Khan, M., & Singh, A. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20354 · Cited by 212 · see citing works

Peroxisomal Disorders: Genotype, Phenotype, Major Neuropathologic Lesions, and Pathogenesis

Powers, J. M., & Moser, H. W. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00139.x · Cited by 208 · see citing works

The Type 1 Interleukin-1 Receptor Is Essential for the Efficient Activation of Microglia and the Induction of Multiple Proinflammatory Mediators in Response to Brain Injury

Basu, A., Krady, J. K., O’Malley, M. E., Styren, S. D., DeKosky, S. T., & Levison, S. W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-06071.2002 · Cited by 165 · see citing works

New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

Lin, C., & Edelson, B. T. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700263 · Cited by 157 · see citing works

Myeloid cell transmigration across the CNS vasculature triggers IL-1β–driven neuroinflammation during autoimmune encephalomyelitis in mice

Lévesque, S. A., Paré, A., Mailhot, B., Bellver‐Landete, V., Kébir, H., Lécuyer, M., Alvarez, J. I., Prat, A., Vaccari, J. P. D. R., Keane, R. W., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151437 · Cited by 151 · see citing works

The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis

Berger, J., Wiesinger, C., & Eichler, F. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s49590 · Cited by 140 · see citing works

General aspects and neuropathology of X-linked adrenoleukodystrophy

Ferrer, I., Aubourg, P., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00390.x · Cited by 139 · see citing works

Microglia and inflammation: Impact on developmental brain injuries

Chew, L., Takanohashi, A., & Bell, M. J. (2006) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20102 · Cited by 134 · see citing works

Adreno-leukodystrophy: Oxidative Stress of Mice and Men

Powers, J. M., Pei, Z., Heinzer, A. K., Brose, R. D., Moser, A. B., Moser, H. W., Watkins, P. A., & Smith, K. D. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000190064.28559.a4 · Cited by 131 · see citing works

Interleukin-1β has trophic effects in microglia and its release is mediated by P2X7R pore

Monif, M., Reid, C. A., Powell, K. L., Drummond, K., O’Brien, T. J., & Williams, D. A. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0621-8 · Cited by 129 · see citing works

Peroxisomes in Immune Response and Inflammation

Cara, F. D., Andreoletti, P., Trompier, D., Véjux, A., Bülow, M. H., Sellin, J., Lizard, G., Cherkaoui‐Malki, M., & Savary, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163877 · Cited by 127 · see citing works

Potential Environmental and Host Participants in the Early White Matter Lesion of Adreno-Leukodystrophy: Morphologic Evidence for CD8 Cytotoxic T Cells, Cytolysis of Oligodendrocytes, and CD1-Mediated Lipid Antigen Presentation

Ito, M., Blumberg, B. M., Mock, D. J., Goodman, A. D., Moser, A. B., Moser, H. W., Smith, K. D., & Powers, J. M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.10.1004 · Cited by 125 · see citing works

Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD:

Paintlia, A. S., Gilg, A. G., Khan, M., Singh, A. K., Barbosa, E., & Singh, I. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.013 · Cited by 120 · see citing works

Interleukin-1 and the Interleukin-1 Type 1 Receptor are Essential for the Progressive Neurodegeneration that Ensues Subsequent to a Mild Hypoxic/Ischemic Injury

Basu, A., Lazović, J., Krady, J. K., Mauger, D. T., Rothstein, R. P., Smith, M. B. H., & Levison, S. W. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600002 · Cited by 118 · see citing works

Acetate supplementation modulates brain histone acetylation and decreases interleukin-1β expression in a rat model of neuroinflammation

Soliman, M. L., Smith, M. D., Houdek, H. M., & Rosenberger, T. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-51 · Cited by 105 · see citing works

Role of Cytokines as Mediators and Regulators of Microglial Activity in Inflammatory Demyelination of the CNS

Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 101 · see citing works

Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production

Albrecht, P. J., Murtie, J. C., Ness, J. K., Redwine, J. M., Enterline, J. R., Armstrong, R. C., & Levison, S. W. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00019-6 · Cited by 99 · see citing works

Chronic IL-1β-Mediated Neuroinflammation Mitigates Amyloid Pathology in a Mouse Model of Alzheimer’s Disease without Inducing Overt Neurodegeneration

Matousek, S. B., Ghosh, S., Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., & O’Banion, M. K. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9331-2 · Cited by 86 · see citing works

Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin

Bsibsi, M., Peferoen, L., Holtman, I., Nacken, P., Gerritsen, W., Witte, M., van Horssen, J., Eggen, B., van der Valk, P., Amor, S., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1317-8 · Cited by 87 · see citing works

IL-1R1 is required for dendritic cell–mediated T cell reactivation within the CNS during West Nile virus encephalitis

Durrant, D. M., Robinette, M. L., & Klein, R. S. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121897 · Cited by 78 · see citing works

Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease

Rossi, B., Santos-Lima, B., Terrabuio, E., Zenaro, E., & Constantin, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639369 · Cited by 79 · see citing works

The neuropsychiatry of adult-onset adrenoleukodystrophy

Rosebush, P. I., Garside, S., Levinson, A. J., & Mazurek, M. F. (1999) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.11.3.315 · Cited by 72 · see citing works

The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders

Luís, J. P., Simões, C. J. V., & Brito, R. M. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031731 · Cited by 69 · see citing works

Inducible nitric oxide synthase in the central nervous system of patients with X-adrenoleukodystrophy

Gilg, A. G., Singh, A. K., & Singh, I. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1063 · Cited by 66 · see citing works

PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism

Altinoz, M. A., & Özpınar, A. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.057 · Cited by 64 · see citing works

Increased expression of pro-inflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper CNS lesions

Markus, S. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00027-9 · Cited by 62 · see citing works

Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury

Lin, H., Basu, A., Druckman, C., Cicchese, M., Krady, J. K., & Levison, S. W. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-15 · Cited by 61 · see citing works

TNFα downregulates PPARδ expression in oligodendrocyte progenitor cells: Implications for demyelinating diseases

Cimini, A., Bernardo, A., Cifone, M. G., Marzio, L. D., & Loreto, S. D. (2002) · Glia · doi:10.1002/glia.10143 · Cited by 59 · see citing works

Streptococcus thermophilus ST285 Alters Pro-Inflammatory to Anti-Inflammatory Cytokine Secretion against Multiple Sclerosis Peptide in Mice

Dargahi, N., Matsoukas, J., & Apostolopoulos, V. (2020) · Brain Sciences · doi:10.3390/brainsci10020126 · Cited by 60 · see citing works

Cytokine mRNA expression in whole blood samples from dogs with natural canine distemper virus infection

Gröne, A., Frisk, A.-L., & Baumgärtner, W. (1998) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(98)00170-6 · Cited by 54 · see citing works

Immune Response in Leukodystrophies

Eichler, F., & van Haren, K. P. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.06.011 · Cited by 47 · see citing works

Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy

Ruíz, M., Jové, M., Schlüter, A., Casasnovas, C., Villarroya, F., Guilera, C., Ortega, F. J., Naudí, A., Pamplona, R., Gimeno, R., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv375 · Cited by 45 · see citing works

Astrocytic ceruloplasmin expression, which is induced by IL‐1β and by traumatic brain injury, increases in the absence of the IL‐1 type 1 receptor

Kuhlow, C. J., Krady, J. K., Basu, A., & Levison, S. W. (2003) · Glia · doi:10.1002/glia.10273 · Cited by 44 · see citing works

Experimental models of spontaneous autoimmune disease in the central nervous system

Krishnamoorthy, G., Holz, A., & Wekerle, H. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0218-x · Cited by 44 · see citing works

Interleukin-1β, -6, -12 and tumor necrosis factor-α expression in brains of dogs with canine distemper virus infection

Gröne, A., Alldinger, S., & Baumgärtner, W. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00332-5 · Cited by 43 · see citing works

X-linked adrenoleukodystrophy enigma: How does the ALD peroxisomal transporter mutation affect CNS glia?

Aubourg, P. R., & Dubois-Dalcq, M. E. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000115)29:2 · Cited by 42 · see citing works

Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity

Lund, T. C., Stadem, P. S., Panoskaltsis‐Mortari, A., Raymond, G. V., Miller, W. P., Tolar, J., & Orchard, P. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032218 · Cited by 41 · see citing works

Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis

Prins, M., Eriksson, C., Wierinckx, A., Bol, J. G. J. M., Binnekade, R., Tilders, F. J. H., & van Dam, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083835 · Cited by 37 · see citing works

Apoptosis in the Central Nervous System of Cerebral Adrenoleukodystrophy Patients

Feigenbaum, V., Gélot, A., Casanova, P., Daumas‐Duport, C., Aubourg, P. R., & Dubois-Dalcq, M. E. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0315 · Cited by 37 · see citing works

Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis

Schmidt, S., Haase, C. G., Bezman, L., Moser, H. W., Schmidt, M., Köhler, W., Linington, C., & Klockgether, T. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00345-9 · Cited by 35 · see citing works

X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype

Maier, E. M., Mayerhofer, P. U., Asheuer, M., Köhler, W., Rothe, M., Muntau, A. C., Roscher, A. A., Holzinger, A., Aubourg, P., & Berger, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.092 · Cited by 34 · see citing works

Anti-Ganglioside Antibodies Bind with Enhanced Affinity to Gangliosides Containing Very Long Chain Fatty Acids

Tagawa, Y., Laroy, W., Nimrichter, L., Fromholt, S., Moser, A. B., Moser, H. W., & Schnaar, R. L. (2002) · Neurochemical Research · doi:10.1023/a:1020221410895 · Cited by 34 · see citing works

Immunopathogenesis of adrenoleukodystrophy: Current understanding

Hudspeth, M. P., & Raymond, G. V. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.10.009 · Cited by 34 · see citing works

Positron Emission Tomography Imaging of Neuroinflammation

Kannan, S., Balakrishnan, B., Muzik, O., Romero, R. J., & Chugani, D. C. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338063 · Cited by 33 · see citing works

‘Prototypical’ proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting

Musella, A., Fresegna, D., Rizzo, F. R., Gentile, A., Vito, F. D., Caioli, S., Guadalupi, L., Bruno, A., Dolcetti, E., Buttari, F., et al. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1709823 · Cited by 32 · see citing works

Genomic Profiling Identifies Novel Mutations and SNPs in ABCD1 Gene: A Molecular, Biochemical and Clinical Analysis of X-ALD Cases in India

Kumar, N., Taneja, K. K., Kalra, V., Behari, M., Aneja, S., & Bansal, S. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025094 · Cited by 25 · see citing works

Th 1 cytokine production by peripheral blood mononuclear cells in X-linked adrenoleukodystrophy

Biase, A. D., Merendino, N., Avellino, C., Cappa, M., & Salvati, S. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00469-x · Cited by 25 · see citing works

Deciphering the modifiers for phenotypic variability of X-linked adrenoleukodystrophy

Palakuzhiyil, S. V., Christopher, R., & Chandra, S. R. (2020) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v11.i3.99 · Cited by 24 · see citing works

Inflammatory profile in X‐linked adrenoleukodystrophy patients: Understanding disease progression

Marchetti, D. P., Donida, B., Jacques, C. E. D., Deon, M., Hauschild, T. C., Koehler‐Santos, P., Coelho, D. D. M., Coitinho, A. S., Jardim, L. B., & Vargas, C. R. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26295 · Cited by 24 · see citing works

Increase of Pro-Inflammatory Cytokine Expression in Non-Demyelinating Early Cerebral Lesions in Nervous Canine Distemper

Beineke, A., Markus, S., Borlak, J. T., Thum, T., & Baumgärtner, W. (2008) · Viral Immunology · doi:10.1089/vim.2008.0043 · Cited by 24 · see citing works

Adrenoleukodystrophy and related disorders

Percy, A. K., & Rutledge, S. L. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1026 · Cited by 21 · see citing works

X-Linked Adrenoleukodystrophy

(2006) · Springer eBooks · doi:10.1007/3-540-29623-9_9160 · Cited by 21 · see citing works

Multiple Sclerosis: Pathogenesis and MR Imaging Features of T1 Hypointensities in Murine Model

Pirko, I., Nolan, T. K., Holland, S. K., & Johnson, A. J. (2008) · Radiology · doi:10.1148/radiol.2463070338 · Cited by 20 · see citing works

Pyroptosis and neurological diseases

Zhao, G., & Xie, Z. (2014) · Neuroimmunology and Neuroinflammation · doi:10.4103/2347-8659.139716 · Cited by 19 · see citing works

Evaluation of Therapy of X-Linked Adrenoleukodystrophy

Moser, H. W., Fatemi, A. S., Zackowski, K. M., Smith, S., Golay, X., Muenz, L. R., & Raymond, G. V. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000021245.12181.90 · Cited by 17 · see citing works

X-linked Adrenoleukodystrophy

Trompier, D., & Savary, S. (2013) · Colloquium Series on The Genetic Basis of Human Disease · doi:10.4199/c00075ed1v01y201303gbd004 · Cited by 16 · see citing works

Functional characterization of the adrenoleukodystrophy protein (ALDP) and disease pathogenesis

Gärtner, J., Dehmel, T., Klusmann, A., & Roerig, P. (2002) · Endocrine Research · doi:10.1081/erc-120016999 · Cited by 15 · see citing works

Adrenoleukodystrophie kann Multiple Sklerose imitieren

Krenn, M., Bonelli, R. M., Niederwieser, G., Reisecker, F., & Költringer, P. (2001) · Der Nervenarzt · doi:10.1007/s001150170037 · Cited by 9 · see citing works

Genetic variations and humoral immune responses to myelin oligodendroglia glycoprotein in adult phenotypes of X-linked adrenoleukodystrophy

Schmidt, S., Marrosu, G. M., Kölsch, H., Haase, C. G., Ferenczik, S., Sokolowski, P., Köhler, W., Schmidt, M., Papassotiropoulos, A., Heun, R., et al. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00445-9 · Cited by 8 · see citing works

Neurometabolic disease

Moser, H. W. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199804000-00002 · Cited by 8 · see citing works

Cerebral inflammation in X-linked adrenoleukodystrophy.

McGuinness, M. C., & Smith, K. D. (1999) · PubMed · Cited by 8 · see citing works

T-cell receptor Vβ gene usage in CSF lymphocytes in X-linked adrenoleukodystrophy

Picard, F., Guidoux, S., Martin, T., Aubourg, P. R., & Pasquali, J. (2004) · Journal of Molecular Recognition · doi:10.1002/jmr.727 · Cited by 7 · see citing works

Inflammation and Immunomodulation in Cerebral X-linked Adrenoleukodystrophy: Review of Pathology and Interventions

Wright, M. A., Demmitt-Rice, C. E., van Haren, K. P., Lund, T. C., Eichler, F., & Bonkowsky, J. L. (2025) · Journal of Child Neurology · doi:10.1177/08830738251353034 · Cited by 4 · see citing works

Adrenoleukodystrophies

Moser, H. W. (2004) · Elsevier eBooks · doi:10.1016/b978-012439510-7/50087-5 · Cited by 4 · see citing works

Chronic inflammatory diseases of the nervous system

Villoslada, P., & Oksenberg, J. R. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199806000-00008 · Cited by 4 · see citing works

Mice Treated Subcutaneously with Mouse LPS-Converted PrPres or LPS Alone Showed Brain Gene Expression Profiles Characteristic of Prion Disease

Hailemariam, D., Goldansaz, S. A., Daude, N., Wishart, D. S., & Ametaj, B. N. (2021) · Veterinary Sciences · doi:10.3390/vetsci8090200 · Cited by 3 · see citing works

Interleukin 1 receptor antagonist and neurodegenerative diseases: the future treatment strategy

Retinasamy, T., & Shaikh, M. F. (2023) · Neuroscience Research Notes · doi:10.31117/neuroscirn.v6i1.164 · Cited by 2 · see citing works

Adrenoleukodystrophy: Molecular, Metabolic, Pathologic, and Therapeutic Aspects

Contreras, M. A., & Singh, I. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_2 · Cited by 2 · see citing works

White Blood Cells in Neurodegenerative Diseases in the Context of Neuroinflammation

Wełnicka, A., & Gołąb-Janowska, M. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05476-2 · Cited by 1 · see citing works

Multiple Sclerosis in an Individual with Intellectual Disability

Barnhill, J. (2007) · Journal of Developmental and Physical Disabilities · doi:10.1007/s10882-007-9096-y · Cited by 1 · see citing works

Dietary Acetate Supplementation Attenuates Neuroinflammation

Soliman, M. L., & Rosenberger, T. A. (2013) · Advances in Neuroimmune Biology · doi:10.3233/nib-130060 · Cited by 1 · see citing works

Peroxisomal diseases

Powers, J. (2008) · CRC Press eBooks · doi:10.1201/b13319-10 · Cited by 1 · see citing works

Activités cytotoxiques et pro-oxydantes d'acides gras à très longue chaîne sur des oligodendrocytes murins sauvages et déficients en Abcd1 et Acox1 : application à la physiopathologie de l'X-ALD et de la P-NALD

Baarine, M. (2010) · theses.fr (ABES) · doi:10.70675/7ab2bcc8z16d2z420cz92f9zb3fd52371382 · Cited by 1 · see citing works

Avaliação de estresse oxidativo em adrenoleucodistrofia ligada ao cromossomo X e doenças do espectro Zellweger

Deon, M. (2009) · Americanae (AECID Library)

NRF2 and RIP140 as new therapeutic targets for X-linked adrenoleukodystrophy (X-ALD): Control of redox/metabolic homeostasis and inflammation

Ranea‐Robles, P. (2017) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)

Effekt von Mycophenolat-Mofetil (CellCept®) auf die Zytokin-Sekretion und NO-Ausschüttung aus mit Lipopolysaccharid (LPS) stimulierte Astrozytenkultur

Schnack, M. (2021) · doi:10.21248/gups.63355

Altérations mitochondriales et processus inflammatoire dans la déficience en acyl- Coenzyme A oxydase 1 peroxysomale

Hajj, H. I. E. (2012) · theses.fr (ABES) · doi:10.70675/f64502b8zb0d3z4fe5zbc45z543a928be0cb

Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes

Bezman, L., & Moser, H. W. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980413)76:5

Cerebral inflammation in X-linked adrenoleukodystrophy.

McGuinness, M. C., & Smith, K. D. (1999) · PubMed · Cited by 8 · see citing works

Association of X-Linked Adrenoleukodystrophy with HLA DRB1 Alleles

Berger, J., Bernheimer, H., Fae, I., Braun, A., Roscher, A., Molzer, B., & Fischer, G. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2643 · Cited by 16 · see citing works

Heat shock protein expression in cerebral X‐linked adrenoleukodystrophy reveals astrocyte stress prior to myelin loss

Görtz, A. L., Peferoen, L. A. N., Gerritsen, W. H., van Noort, J. M., Bugiani, M., & Amor, S. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12399 · Cited by 37 · see citing works

Inflammatory profile in X‐linked adrenoleukodystrophy patients: Understanding disease progression

Marchetti, D. P., Donida, B., Jacques, C. E. D., Deon, M., Hauschild, T. C., Koehler‐Santos, P., Coelho, D. D. M., Coitinho, A. S., Jardim, L. B., & Vargas, C. R. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26295 · Cited by 24 · see citing works

Tumor necrosis factor-α and X-linked adrenoleukodystrophy

McGuinness, M. C., Griffin, D. E., Raymond, G. V., Washington, C., Moser, H. W., & Smith, K. D. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00084-f · Cited by 54 · see citing works